Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial - Elgadi, Mabrouk M.; Piliero, Peter J. (Drugs in R&D, 2011)
Keywords: Adult; Complications and side effects; Darunavir; Drug therapy; Female; Gastrointestinal Diseases - chemically induced; Gastrointestinal Diseases - immunology; HIV infection; HIV Infections - drug therapy; HIV Infections - immunology; HIV-1 - drug effects; HIV-1 - growth & development; Humans; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Pharmacology/Toxicology; Pharmacotherapy; Prospective Studies; Pyridines - administration & dosage; Pyridines - adverse effects; Pyrones - administration & dosage; Pyrones - adverse effects; Short Communication; Sulfonamides - administration & dosage; Sulfonamides - adverse effects; Treatment Outcome; Viral Load - immunology; United States; Darunavir; Maraviroc; Nucleoside Reverse Transcriptase Inhibitor; Viral Load; Raltegravir